The Combined Effect of Nanobubble-IR783-HPPH-Affibody Complex and Laser on HER2-Positive Breast Cancer

INTRODUCTION: Nanobubble is an innovative ultrasound contrast agent that triggers the development of targeted imaging of HER2-positive breast cancer by combining with HER2 affibody and IR783. HPPH is a second-generation photosensitiser that is effective in treating tumours. Hence, the nanobubble-IR7...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Wenbin, Lv, Wei, Meng, Li, Duan, Yunyou, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871049/
https://www.ncbi.nlm.nih.gov/pubmed/36703724
http://dx.doi.org/10.2147/IJN.S387409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871049/
https://www.ncbi.nlm.nih.gov/pubmed/36703724
http://dx.doi.org/10.2147/IJN.S387409

Ejemplares similares